Literature DB >> 18620896

Verrucous carcinoma of the oral cavity: A clinical and pathological study of 101 cases.

Rohan R Walvekar1, Devendra A Chaukar, Mandar S Deshpande, Prathamesh S Pai, Pankaj Chaturvedi, Anagha Kakade, Subhadra V Kane, Anil K D'Cruz.   

Abstract

This paper studies the clinical and pathological predictors of local recurrence and disease-free survival (DFS) in patients with oral verrucous carcinoma (OVC) treated surgically, through a retrospective chart review. Three hundred and two patients with OVC were identified from January 1990 to December 2000, of which, 101 surgically treated patients who fulfilled our inclusion criteria were analyzed. A univariate analysis (UVA) of important prognostic factors, patterns of recurrence, and DFS is reported. Seventy-nine patients were male (M:F ratio, 3.6:1) and the mean age at presentation was 53.9 years (range, 23-90 years). The median follow up was 4.61 years (range, 0.51-14.3 years). The incidence of tobacco chewing, smoking, and alcohol intake was 77%, 42%, and 10%, respectively. Thirty-four patients (33.7%) had either leukoplakia or submucous fibrosis (SMF) on oral cavity examination. Early-stage tumors accounted for 39.7%; while 60.4% were late-stage tumors. On UVA, tumor location, presence of a premalignant lesion, smoking, and positive margins were statistically significant. Sixty-eight percent (19/28) recurred locally. The salvage rate for recurrent tumors was 66.7% (16/28) with a median post-recurrence survival of 16 months (range, 10-83 months). The five year DFS with surgical therapy was 77.6%. OVC has an excellent prognosis with surgical treatment. The significance of positive margins emphasizes the need for adequate surgical resection. Additionally, the presence of either leukoplakia or SMF and tumor location in the upper alveolar-palatal complex is associated with worse outcomes. Neck dissection, if considered, may be limited to a supra-omohyoid neck dissection (SOHND).

Entities:  

Mesh:

Year:  2008        PMID: 18620896     DOI: 10.1016/j.oraloncology.2008.03.014

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  38 in total

1.  Clinical Challenges in Resection and Reconstruction of a Verrucous Carcinoma of the Right Calcaneus With a Medial Plantar Artery Perforator Flap: A Case Report.

Authors:  Frank De Jongh; Sjaak Pouwels; Andreas Marinelli; Wouter F Willems
Journal:  Cureus       Date:  2021-02-04

2.  Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.

Authors:  Suresh Mohan; Sara I Pai; Neil Bhattacharyya
Journal:  Laryngoscope       Date:  2017-02-01       Impact factor: 3.325

3.  Verrucous carcinoma (carcinoma cuniculatum) of the head and neck: what do we know now that we did not know a decade ago?

Authors:  Kenneth O Devaney; Alfio Ferlito; Alessandra Rinaldo; Adel K El-Naggar; Leon Barnes
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-01       Impact factor: 2.503

Review 4.  Squamous cell carcinoma of the upper aerodigestive tract: dysplasia and select variants.

Authors:  Bruce M Wenig
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

5.  When is surgical therapy for head and neck malignant epithelial tumors not indicated?

Authors:  Carlos Suárez; Robert P Takes; Carl E Silver; Juan P Rodrigo; Primož Strojan; Julia A Woolgar; Missak Haigentz; H Hakan Coskun; Remco de Bree; Randall P Owen; Mohamed N Elsheikh; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-04       Impact factor: 2.503

6.  Evaluation of the toxic potential of arecoline toward the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ) Bg9.

Authors:  Barkha Shakya; Yasir Hasan Siddique
Journal:  Toxicol Res (Camb)       Date:  2018-03-20       Impact factor: 3.524

7.  Expression of αB-crystallin and its potential anti-apoptotic role in oral verrucous carcinoma.

Authors:  Hongzhi Quan; Zhangui Tang; Lily Zhao; Yuehong Wang; Ousheng Liu; Zhigang Yao; Jun Zuo
Journal:  Oncol Lett       Date:  2011-11-02       Impact factor: 2.967

8.  Research on miRNA-195 and target gene CDK6 in oral verrucous carcinoma.

Authors:  Z Deng; Y Wang; X Fang; F Yan; H Pan; L Gu; C Xie; Y Li; Y Hu; Y Cao; Z Tang
Journal:  Cancer Gene Ther       Date:  2017-06-16       Impact factor: 5.987

9.  Oral hybrid verrucous carcinoma: a clinical study.

Authors:  Sandhya Gokavarapu; L M Chandrasekhara Rao S; Uma Sankar Tantravahi; Sandhya Devi Gundimeda; T Subramaneshwar Rao; Sudha Murthy
Journal:  Indian J Surg Oncol       Date:  2014-08-28

10.  A Case of Squamous Cell Carcinoma in the External Auditory Canal Previously Treated for Verrucous Carcinoma.

Authors:  Soo Jung Nam; Chan Joo Yang; Jong Woo Chung
Journal:  J Audiol Otol       Date:  2016-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.